EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Betamethasone transdermal administration combined with fractional Er: YAG lasers or microplasma radiofrequency technology improved hypertrophic scars: A retrospective study

Liu Liu, Huizheng Li, Wen Zhang, Mo Cao, Lisha Yu, Xingjian Cheng iD

Journal of Cosmetic Dermatology · 2024

DOI: 10.1111/jocd.16304 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Liu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Plastic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Betamethasone, Administration, Cutaneous, Lasers, Solid-State, Cicatrix, Hypertrophic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Youth Science and Technology Project of the Hebei Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This retrospective study aims to compare the efficacy rates in treating hypertrophic scars among four distinct groups of patients who either underwent fractional Erbium: yttrium‐aluminum‐garnet (Er:YAG) laser or microplasma radiofrequency technology as standalone treatments or in combination with compound betamethasone transdermal administration.

Method

The study retrospectively examined 208 patients treated at our institution from April 2011 to December 2022 for hypertrophic scars, receiving no less than three treatments (with an interval of 8 weeks between each). The patients were categorized into four groups: the F group (treated with fractional Er:YAG laser), the F + B group (treated with fractional Er:YAG laser combined with compound betamethasone transdermal administration), the P group (treated with microplasma radiofrequency technology), and the P + B group (treated with microplasma radiofrequency technology combined with compound betamethasone transdermal administration). The therapeutic effects were evaluated based on the changes in the Vancouver Scar Scale (VSS) scores before and after treatment in these groups.

Results

There was no statistically significant difference in the VSS scores among the four groups before treatment. After undergoing three sessions of the aforementioned four types of treatment, all groups showed a decrease in VSS scores, with average posttreatment VSS scores for the F group scored 5.15 ± 2.084, F + B group scored 3.7 ± 1.781, P group scored 4.41 ± 1.933, and P + B group scored 3.16 ± 1.775, respectively. With an increasing number of treatments, the total effective rate gradually increased in all four groups, and the combination treatment using compound betamethasone transdermal administration proved more effective than the standalone treatment.

Conclusion

All four treatments yielded favorable outcomes, with the combined therapy involving compound betamethasone transdermal administration proving more effective than the standalone treatments, meriting further clinical attention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BetamethasoneAdministration, CutaneousLasers, Solid-StateCicatrix, HypertrophicHumansRetrospective StudiesFemaleMaleAdultCombined Modality TherapyTreatment OutcomeMiddle AgedGlucocorticoidsYoung AdultLow-Level Light TherapyAdolescent

Stichwörter der Autor:innen

betamethasonefractional lasershypertrophic scarsmicroplasmatransdermal administration

Substanzen

BetamethasoneGlucocorticoids

Autor:innen und Institutionen

  • Department of Dermatology and Plastic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.

ORCID-Profile: Xingjian Cheng

Förderung

  • Youth Science and Technology Project of the Hebei Health Commission

Zitieren

APA

Liu, L., Li, H., Zhang, W., Cao, M., Yu, L., & Cheng, X. (2024). Betamethasone transdermal administration combined with fractional Er: YAG lasers or microplasma radiofrequency technology improved hypertrophic scars: A retrospective study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16304

Vancouver

Liu L, Li H, Zhang W, Cao M, Yu L, Cheng X. Betamethasone transdermal administration combined with fractional Er: YAG lasers or microplasma radiofrequency technology improved hypertrophic scars: A retrospective study. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16304

BibTeX
@article{Liu2024,
  author = {Liu, Liu and Li, Huizheng and Zhang, Wen and Cao, Mo and Yu, Lisha and Cheng, Xingjian},
  title = {Betamethasone transdermal administration combined with fractional Er: YAG lasers or microplasma radiofrequency technology improved hypertrophic scars: A retrospective study},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  doi = {10.1111/jocd.16304}
}
Kostenlos starten →